Caffeine prevents weight gain and cognitive impairment caused by a high-fat diet while elevating hippocampal BDNF

Physiology and Behavior

Volumn 109, Issue 1, 2013, Pages 69-74

  Moy, Gregory A ^a   McNay, Ewan C ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Alzheimer's; BDNF; Caffeine; Diabetes; Hippocampus; Insulin; Learning; Memory

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CAFFEINE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; COGNITIVE DEFECT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; IN VIVO STUDY; INSULIN BLOOD LEVEL; LIPID DIET; MALE; MICRODIALYSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPATIAL MEMORY; WEIGHT GAIN; WORKING MEMORY;

EID: 84871650697     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2012.11.008     Document Type: Article

References (83)

1. Flegal K.M., Carroll M.D., Ogden C.L., Curtin L.R. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303(3):235-241.
2. Banas S.M., et al. A dietary fat excess alters metabolic and neuroendocrine responses before the onset of metabolic diseases. Cell Mol Neurobiol 2009, 29(2):157-168.
3. Davis J.F., et al. Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat. Behav Neurosci 2008, 122(6):1257-1263.
4. Farr S.A., et al. Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology 2008, 149(5):2628-2636.
5. Gerges N.Z., Aleisa A.M., Alkadhi K.A. Impaired long-term potentiation in obese Zucker rats: possible involvement of presynaptic mechanism. Neuroscience 2003, 120(2):535-539.
6. Lindqvist A., et al. High-fat diet impairs hippocampal neurogenesis in male rats. Eur J Neurol 2006, 13(12):1385-1388.
7. Moroz N., et al. Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus. J Alzheimers Dis 2008, 15(1):29-44.
8. Souza C.G., et al. Highly palatable diet consumption increases protein oxidation in rat frontal cortex and anxiety-like behavior. Life Sci 2007, 81(3):198-203.
9. Stranahan A.M., Mattson M.P. Impact of energy intake and expenditure on neuronal plasticity. Neuromolecular Med 2008, 10(4):209-218.
10. Van Den Berg E., et al. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: a systematic comparison of their impact on cognition. Biochim Biophys Acta 2009, 1792(5):470-481.
11. Winocur G., Greenwood C.E. Studies of the effects of high fat diets on cognitive function in a rat model. Neurobiol Aging 2005, 26(Suppl. 1):46-49.
12. Winocur G., et al. Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity. Behav Neurosci 2005, 119(5):1389-1395.
13. Harris M.I., Flegal K.M., Cowie C.C., Eberhardt M.S., Goldstein D.E., Little R.R., et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998, 21(4):518-524.
14. DeFronzo R.A., Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14(3):173-194.
15. Akisaki T., et al. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 2006, 22(5):376-384.
16. Awad N., Gagnon M., Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 2004, 26(8):1044-1080.
17. Brands A.M., et al. Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: a comparative study. Dement Geriatr Cogn Disord 2007, 23(5):343-350.
18. Cosway R., et al. Cognitive function and information processing in type 2 diabetes. Diabet Med 2001, 18(10):803-810.
19. Den Heijer T., et al. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 2003, 46(12):1604-1610.
20. Gold S.M., et al. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 2007, 50(4):711-719.
21. Hassing L., et al. Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study. J Int Neuropsychol Soc 2004, 10(4):599-607.
22. McNay E.C., et al. Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem 2010, 93(4):546-553.
23. Fredholm B.B., Battig K., Holmen J., Nehlig A., Zvartau E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999, 51(1):83-153.
24. Julien R.M. A primer of drug action: a comprehensive guide to the actions, uses, and side effects of psychoactive drugs 2007, Worth Publishers, New York, NY. Eleventh Edition.
25. Akiba T., Yaguchi K., Tsutsumi K., Nishioka T., Koyama I., Nomura M., et al. Inhibitory mechanism of caffeine on insulin-stimulated glucose uptake in adipose cells. Biochem Pharmacol 2004, 68(10):1929-1937.
26. Duarte J.M.N., Carvalho R.A., Cunhn R.A., Gruetter R. Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin-induced diabetic rats. J Neurochem 2009, 111(2):368-379.
27. Kerr D., Sherwin R.S., Pavalkis F., Fayad P.B., Sikorski L., Rife F., et al. Effect of caffeine on the recognition of and responses to hypoglycemia in humans. Ann Intern Med 1993, 119(8):799-804.
28. Van Dam R.M., Willett W.C., Manson J.E., Hu F.B. Coffee, caffeine, and risk of type 2 diabetes. Diabetes Care 2006, 19(2):398-403.
29. Pimentel G.D., Zemdegs J.C.S., Theodoro J.A., Mota J.A. Does long-term coffee intake reduce type 2 diabetes mellitus risk?. Diabetol Metab Syndr 2009, 1(6):1-8.
30. Duarte J.M., et al. Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10/LTJ mice. PLoS One 2012, 7(4):e21899.
31. Chen X., Gawryluk J.W., Wagener J.F., Ghribi O., Geiger J.D. Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease. J Neuroinflammation 2008, 5(12).
32. Nakaso K., Ito S., Nakashima K. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells. Neurosci Lett 2008, 43(2):146-150.
33. Hashimoto T., He Z., Ma W.Y., Schmid P.C., Bode A.M., Yang C.S., et al. Caffeine inhibits cell proliferation by G0/G1 phase arrest in JB6 cells. Cancer Res 2004, 64(9):3344-3349.
34. Loke W.H. Effects of caffeine on mood and memory. Physiol Behav 1988, 44(3):367-372.
35. Nehlig A., Daval J.L., Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev 1992, 17(2):139-170.
36. Arendash G.W., Schleif W., Rezai-Zadeh K., Jackson E.K., Zacharia L.C., Cracchiolo J.R., et al. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain β-amyloid production. Neuroscience 2006, 142(4):941-952.
37. Arendash G.W., Mori T., Cao C., Mamcarz M., Runfeldt M., Dickson A., et al. Caffeine reverses cognitive impairment and decreases brain amyloid-β levels in aged Alzheimer's disease mice. J Alzheimer's Dis 2009, 17(3):661-680.
38. de la Monte S.M. Insulin resistance and Alzheimer's disease. BMB Rep 2009, 42(8):475-481.
39. Irie F., et al. Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE {varepsilon}4: the cardiovascular health study cognition study. Arch Neurol 2008, 65(1):89-93.
40. Janson J., et al. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 2004, 53(2):474-481.
41. Nelson P.T., et al. Human cerebral neuropathology of type 2 diabetes mellitus. Biochim Biophys Acta 2009, 1792(5):454-469.
42. Suzanne M.D.L.M., Jack R.W. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimers Dis 2005, 7(1):45-61.
43. Zhao W.Q., Townsend M. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease. Biochim Biophys Acta 2009, 1792(5):482-496.
44. Chen J.F., Xu K., Petzer J.P., Staal R., Xu Y.H., Beilstein M., et al. Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci 2001, 21(10):RC143.
45. Prediger R.D. Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms. J Alzheimer's Dis 2010, 20(1):205-220.
46. McNay E.C., Recknagel A.K. Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes. Neurobiol Learn Mem 2011, 96(3):432-442.
47. McNay E., et al. Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem 2010, 93(4):546-553.
48. Levin B.E., et al. Selective breeding for diet-induced obesity and insulin resistance in Sprague-Dawley rats. Am J Physiol 1997, 273:R725-R730.
49. Clegg D.J., et al. Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet. Am J Physiol Regul Integr Comp Physiol 2005, 288(4):R981-R986.
50. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112(2):257-269.
51. Yamada K., Mizuno M., Nabeshima T. Role for brain-derived neurotrophic factor in learning and memory. Life Sci 2002, 70(7):735-744.
52. Hall J., Thomas K.L., Everitt B.J. Rapid and selective induction of BDNF expression in the hippocampus during contextual learning. Nat Neurosci 2000, 3(6):533-535.
53. McNay E.C., Fries T.M., Gold P.E. Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task. Proc Natl Acad Sci U S A 2000, 97(6):2881-2885.
54. McNay E.C., Sherwin R.S. From artificial cerebro-spinal fluid (aCSF) to artificial extracellular fluid (aECF): microdialysis perfusate composition effects on in vivo brain ECF glucose measurements. J Neurosci Methods 2004, 132(1):35-43.
55. McNay E.C., et al. Cognitive and neural hippocampal effects of long-term moderate recurrent hypoglycemia. Diabetes 2006, 55(4):1088-1095.
56. McNay E., Gold P. Extracellular glucose concentrations in the rat hippocampus measured by zero-net-flux: effects of microdialysis flow rate, strain, and age. J Neurochem 1999, 72:785-790.
57. McNay E.C., Gold P.E. Memory modulation across neural systems: intra-amygdala glucose reverses deficits caused by intraseptal morphine on a spatial task but not on an aversive task. J Neurosci 1998, 18(10):3853-3858.
58. Dember W.N., Fowler H. Spontaneous alternation behavior. Psychol Bull 1958, 55(6):412-428.
59. Stevens R., Cowey A. Effects of dorsal and ventral hippocampal lesions on spontaneous alternation, learned alternation and probability learning in rats. Brain Res 1973, 52:203-224.
60. Richman C., Dember W., Kim P. Spontaneous alternation behavior in animals: a review. Curr Psychol 1986, 5(4):358-391.
61. Dember, W.N., Spontaneous Alternation, ed. R. CL1989, New York: Springer.
62. Stefani M.R., Nicholson G.M., Gold P.E. ATP-sensitive potassium channel blockade enhances spontaneous alternation performance in the rat: a potential mechanism for glucose-mediated memory enhancement. Neuroscience 1999, 93(2):557-563.
63. Winocur G., Greenwood C.E. The effects of high fat diets and environmental influences on cognitive performance in rats. Behav Brain Res 1999, 101(2):153-161.
64. Lalonde R. The neurobiological basis of spontaneous alternation. Neurosci Biobehav Rev 2002, 26(1):91-104.
65. Shah A.A., Parent M.B. Septal infusions of glucose or pyruvate with muscimol impair spontaneous alternation. Brain Res 2004, 996(2):246-250.
66. Pych J., et al. Acetylcholine release in hippocampus and striatum during testing on a rewarded spontaneous alternation task. Neurobiol Learn Mem 2005, 84:93-101.
67. Krebs-Kraft D.L., Parent M.B. Hippocampal infusions of glucose reverse memory deficits produced by co-infusions of a GABA receptor agonist. Neurobiol Learn Mem 2008, 89(2):142-152.
68. Pearson-Leary J., McNay E.C. Intrahippocampal administration of amyloid-β1-42 oligomers acutely impairs spatial working memory, insulin signalling, and hippocampal metabolism. J Alzheimers Dis 2012, 29:1-10.
69. McNay E.C., Recknagel A.K. Brain insulin signaling: A key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes. Neurobiol Learn Mem 2011, 96(3):432-442.
70. Costa M.S., et al. Caffeine improves adult mice performance in the object recognition task and increases BDNF and TrkB independent on phospho-CREB immunocontent in the hippocampus. Neurochem Int 2008, 53(3-4):89-94.
71. Costa M.S., et al. Caffeine prevents age-associated recognition memory decline and changes brain-derived neurotrophic factor and tirosine kinase receptor (TrkB) content in mice. Neuroscience 2008, 153(4):1071-1078.
72. Alhaider I.A., et al. Sleep deprivation prevents stimulation-induced increases of levels of P-CREB and BDNF: protection by caffeine. Mol Cell Neurosci 2011, 46(4):742-751.
73. Balkowiec A., Katz D.M. Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons. J Neurosci 2002, 22(23):10399-10407.
74. Connolly S., Kingsbury T.J. Caffeine modulates CREB-dependent gene expression in developing cortical neurons. Biochem Biophys Res Commun 2010, 397(2):152-156.
75. Santi S., et al. Hippocampal neurons recycle BDNF for activity-dependent secretion and LTP maintenance. EMBO J 2006, 25(18):4372-4380.
76. McNay E.C., Ong C.T., McCrimmon R.J., Cresswell J., Bogan J.S., Sherwin R.S. Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem 2010, 93(4):546-553.
77. Julien C., et al. High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model. Neurobiol Aging 2008, 31(9):1516-1531.
78. Wu A., Ying Z., Gomez-Pinilla F. The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur J Neurosci 2004, 19(7):1699-1707.
79. Dandona P., et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?. J Clin Endocrinol Metab 2001, 86(7):3257-3265.
80. Merighi S., Benini A., Mirandola P., Gessi S., Varani S., Simioni C., et al. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells. Mol Pharmacol 2007, 72(2):395-406.
81. Tong L., Balazs R., Soiampornkul R., Thangnipon W., Cotman C.W. Interleukin-1β impairs brain derived neurotrophic factor-induced signal transduction. Neurobiol Aging 2008, 29(9):1380-1393.
82. Vila-Luna S., et al. Chronic caffeine consumption prevents cognitive decline from young to middle age in rats, and is associated with increased length, branching, and spine density of basal dendrites in CA1 hippocampal neurons. Neuroscience 2012, 202:384-395.
83. Simons S.B., et al. Caffeine-induced synaptic potentiation in hippocampal CA2 neurons. Nat Neurosci 2012, 15(1):23-25.